Scleritis and Peripheral Ulcerative Keratitis

Anat Galor, Jennifer E. Thorne

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Scleritis and peripheral ulcerative keratitis (PUK) can present as isolated conditions or as part of a systemic inflammatory or infectious disorder. Both are serious ocular conditions that can result in vision loss and require early diagnosis and treatment. Nearly two thirds of patients with non-infectious scleritis require systemic glucocorticoid therapy and one fourth need a glucocorticoid-sparing agent as well. Essentially all patients with non-infectious PUK require systemic glucocorticoids. A detailed clinical history, thorough physical examination, and thoughtful laboratory evaluations are important in the exclusion of underlying disorders and extraocular involvement.

Original languageEnglish
Pages (from-to)835-854
Number of pages20
JournalRheumatic Disease Clinics of North America
Volume33
Issue number4
DOIs
StatePublished - Nov 1 2007
Externally publishedYes

Fingerprint

Scleritis
Corneal Ulcer
Glucocorticoids
Physical Examination
Early Diagnosis
Therapeutics

ASJC Scopus subject areas

  • Rheumatology

Cite this

Scleritis and Peripheral Ulcerative Keratitis. / Galor, Anat; Thorne, Jennifer E.

In: Rheumatic Disease Clinics of North America, Vol. 33, No. 4, 01.11.2007, p. 835-854.

Research output: Contribution to journalArticle

Galor, Anat ; Thorne, Jennifer E. / Scleritis and Peripheral Ulcerative Keratitis. In: Rheumatic Disease Clinics of North America. 2007 ; Vol. 33, No. 4. pp. 835-854.
@article{ae4ad303ec7a4cc09b0aaa94ae871f4c,
title = "Scleritis and Peripheral Ulcerative Keratitis",
abstract = "Scleritis and peripheral ulcerative keratitis (PUK) can present as isolated conditions or as part of a systemic inflammatory or infectious disorder. Both are serious ocular conditions that can result in vision loss and require early diagnosis and treatment. Nearly two thirds of patients with non-infectious scleritis require systemic glucocorticoid therapy and one fourth need a glucocorticoid-sparing agent as well. Essentially all patients with non-infectious PUK require systemic glucocorticoids. A detailed clinical history, thorough physical examination, and thoughtful laboratory evaluations are important in the exclusion of underlying disorders and extraocular involvement.",
author = "Anat Galor and Thorne, {Jennifer E.}",
year = "2007",
month = "11",
day = "1",
doi = "10.1016/j.rdc.2007.08.002",
language = "English",
volume = "33",
pages = "835--854",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Scleritis and Peripheral Ulcerative Keratitis

AU - Galor, Anat

AU - Thorne, Jennifer E.

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Scleritis and peripheral ulcerative keratitis (PUK) can present as isolated conditions or as part of a systemic inflammatory or infectious disorder. Both are serious ocular conditions that can result in vision loss and require early diagnosis and treatment. Nearly two thirds of patients with non-infectious scleritis require systemic glucocorticoid therapy and one fourth need a glucocorticoid-sparing agent as well. Essentially all patients with non-infectious PUK require systemic glucocorticoids. A detailed clinical history, thorough physical examination, and thoughtful laboratory evaluations are important in the exclusion of underlying disorders and extraocular involvement.

AB - Scleritis and peripheral ulcerative keratitis (PUK) can present as isolated conditions or as part of a systemic inflammatory or infectious disorder. Both are serious ocular conditions that can result in vision loss and require early diagnosis and treatment. Nearly two thirds of patients with non-infectious scleritis require systemic glucocorticoid therapy and one fourth need a glucocorticoid-sparing agent as well. Essentially all patients with non-infectious PUK require systemic glucocorticoids. A detailed clinical history, thorough physical examination, and thoughtful laboratory evaluations are important in the exclusion of underlying disorders and extraocular involvement.

UR - http://www.scopus.com/inward/record.url?scp=36248954411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36248954411&partnerID=8YFLogxK

U2 - 10.1016/j.rdc.2007.08.002

DO - 10.1016/j.rdc.2007.08.002

M3 - Article

C2 - 18037120

AN - SCOPUS:36248954411

VL - 33

SP - 835

EP - 854

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 4

ER -